Pinar Yurdakul Mesutoglu

Ex vivo expansion of natural killer cells for hematological cancer immunotherapy: a systematic review and meta-analysis

G. Seval, H. Çubukçu, M. Beksaç, 2022, Clinical and Experimental Medicine.

A Novel Hypothesis: Certain KIR/Cognate Ligand Containing Genotypes Differ in Frequency Among Patients With Myeloma and Have an Effect on Age of Disease Onset.

G. Gurman, G. Seval, K. Dalva, 2023, Clinical lymphoma, myeloma & leukemia.